Skip to main content
. 2019 May 24;24(9):e870–e879. doi: 10.1634/theoncologist.2018-0791

Table 3. The risk factors for disease progression and mortality among patients with uterine and cervical adenosarcoma.

image

Bolded p values are statistically significant.

Abbreviations: —, null; FIGO, International Federation of Gynecology and Obstetrics; FSS, fertility‐sparing surgery; HE, heterologous elements; LVSI, lymphovascular space invasion; SO, sarcomatous overgrowth.